55682-49-0 Usage
General Description
1,6-di-O-acetyl-2-azido-3,4-di-O-benzyl-2-deoxy-α-D-glucopyranose is a compound that belongs to the class of carbohydrates and is a derivative of glucose. It is a complex chemical with a specific molecular structure, consisting of acetyl and benzyl groups attached to different positions of the glucose molecule. The presence of azido and deoxy moieties further adds to its complexity. 1,6-di-O-acetyl-2-azido-3,4-di-O-benzyl-2-deoxy-α-D-glucopyranose has potential applications in the field of organic synthesis, medicinal chemistry, and biochemistry due to its ability to selectively interact with specific biological molecules and its potential to be used as a substrate for various enzymatic reactions. Its unique chemical structure makes it a valuable tool for understanding and manipulating biological processes and for the development of new therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 55682-49-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,5,6,8 and 2 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 55682-49:
(7*5)+(6*5)+(5*6)+(4*8)+(3*2)+(2*4)+(1*9)=150
150 % 10 = 0
So 55682-49-0 is a valid CAS Registry Number.
55682-49-0Relevant articles and documents
PROCESS FOR PREPARING HEPARINOIDS AND INTERMEDIATES USEFUL IN THE SYNTHESIS THEREOF
-
, (2013/02/28)
Processes are disclosed for the synthesis of the Factor Xa anticoagulant fondaparinux and related compounds. Protected pentasaccharide intermediates and efficient and scalable processes for the industrial scale production of fondaparinux sodium by conversion of the protected pentasaccharide intermediates via a sequence of deprotection and sulfonation reactions are provided.
OLIGOSACCHARIDE COMPOUNDS FOR USE IN MOBILISING STEM CELLS
-
Page/Page column 33; 35, (2010/04/06)
A compound of the following formula or a salt, solvate or formula (I) and a pharmaceutical composition containing said compound. It concerns also its use in the treatment of cancer and/or of pathological angiogenesis and/or in promoting the mobilisation of stem cells, in particular hematopoietic stem cells.
